Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-17

Clinical Trial Update: Effect of Levosimendan or Placebo on Exercise in Advanced Chronic Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing the effect of levosimendan versus placebo on exercise capacity in advanced chronic heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levosimendan (levosimendan)

Snippet

Sponsor: Finn Gustafsson | Conditions: Heart Failure | Phase 4 | Status: UNKNOWN